Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
47.74
+1.52 (3.29%)
At close: Sep 26, 2025, 4:00 PM EDT
47.67
-0.07 (-0.15%)
After-hours: Sep 26, 2025, 7:56 PM EDT

Akero Therapeutics Stock Forecast

Stock Price Forecast

According to 8 professional analysts, the 12-month price target for Akero Therapeutics stock ranges from a low of $64 to a high of $109. The average analyst price target of $80.38 forecasts a 68.37% increase in the stock price over the next year.

Price Target: $80.38 (+68.37%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $64 $80.38 $76 $109
Change +34.06% +68.37% +59.20% +128.32%

Analyst Ratings

The average analyst rating for Akero Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Apr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy 555567
Buy 433311
Hold 000000
Sell 000000
Strong Sell 000000
Total 988878

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$72
Strong Buy Initiates $72 +50.82% Sep 4, 2025
TD Cowen
TD Cowen
Strong Buy
Initiates
$76
Strong Buy Initiates $76 +59.20% Aug 4, 2025
B of A Securities
B of A Securities
Strong Buy
Maintains
$63$64
Strong Buy Maintains $63$64 +34.06% May 27, 2025
Citigroup
Citigroup
Strong Buy
Maintains
$80$78
Strong Buy Maintains $80$78 +63.39% May 13, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$72$75
Strong Buy Maintains $72$75 +57.10% Mar 3, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.69
from -3.75
EPS Next Year
-4.33
from -3.69
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
-------
Revenue Growth
-------
EPS
-2.52-2.89-2.87-2.89-3.75-3.69-4.33
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1312
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 20252026202720282029
High - -
Avg - -
Low - -

EPS Forecast

EPS 20252026202720282029
High -3.76 -4.07
Avg -3.69 -4.33
Low -3.66 -4.80

EPS Growth

EPS Growth 20252026202720282029
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.